Page 6 - யார்க் பல்கலைக்கழகம் பள்ளி ஆஃப் மருந்து News Today : Breaking News, Live Updates & Top Stories | Vimarsana

J&J Vaccine Significantly Less Effective Against CCP Virus Variants, Study Suggests The Johnson & Johnson vaccine against COVID-19 is significantly less effective against variants compared to the two other COVID-19 vaccines approved for use in the United States, a pre-print study by scientists from the New York University School of Medicine suggests. According to the paper’s summary, the antibodies elicited by the Pfizer-BioNTech and Moderna vaccines “showed modest neutralization resistance against Beta, Delta, Delta plus and Lambda variants.” In contrast, the antibodies generated in response to the Johnson & Johnson vaccine had “significantly decreased neutralization.” “The data underscore the importance of surveillance for breakthrough infections that result in severe COVID-19 and suggest the benefit of a second immunization following [the Johnson & Johnson vaccine] to increase protection against the variants,” the study states.

United statesNaftali bennettJen psakiYork university school of medicineWhite houseChinese communist partyNew york university schoolEpoch timesIsraeli prime minister naftali bennettPrime minister naftali bennettLos angeles countyWhite house press secretary jen psakiஒன்றுபட்டது மாநிலங்களில்நாப்தளி பென்னட்யார்க் பல்கலைக்கழகம் பள்ளி ஆஃப் மருந்துவெள்ளை வீடு